SCHEMBL2494412

SCHEMBL2494412

CN(CCCO)c1cccc(-c2ccccc2F)c1-c1ccccc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
PABPC1 P11940 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34
SLC6A9 P48067 2/20 0.34
GCGR P47871 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GBA1 P04062 1/20 0.32
HTR1A P08908 4/20 0.32
HTR7 P34969 4/20 0.32
TAAR1 Q96RJ0 1/20 0.32
PDK2 Q15119 2/20 0.32
ACKR3 P25106 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
CRHBP P24387 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491971 0.91 MEN1 (0.40) MEN1KMT2APABPC1SLC6A9KDM4E
SCHEMBL2491885 0.81 MEN1 (0.39) MEN1KMT2APABPC1SLC6A9KDM4E
SCHEMBL2492754 0.78 HTR7 (0.48) MEN1KMT2ASLC6A9KDM4EHTR1A
SCHEMBL2490780 0.72 MEN1 (0.46) MEN1KMT2APABPC1SLC6A9KDM4E
SCHEMBL16701641 0.71 TAAR1 (0.41) MEN1KMT2APABPC1KDM4ETAAR1
SCHEMBL31243236 0.70 ALDH1A1 (0.42) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL31243237 0.70 ALDH1A1 (0.42) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL1723682 0.70 ALDH1A1 (0.42) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL2491890 0.69 MEN1 (0.33) MEN1KMT2AFFAR4KDM4EHTR7
SCHEMBL2488726 0.69 HTR7 (0.50) MEN1KMT2APABPC1SLC6A9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MEN1 1585/4885KMT2A 2108/4885PABPC1 4142/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MEN1 1346/4885KMT2A 2219/4885PABPC1 4058/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MEN1 1200/4885KMT2A 2287/4885PABPC1 4079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.